XIIDERI

Swiss trademark · 706458 · Word mark · In force

Register entry

Registration number
706458
Application number
53528/2017
Status
In force
Type
Word mark
Filed
Mar 20, 2017
Registered
Aug 24, 2017
Published
Aug 24, 2017
Protected until
Mar 20, 2027
Source
Swissreg

Goods and services

Pharmaceuticals

Augentropfen; pharmazeutische Präparate zur Behandlung des trockenen Auges.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 6, 2024

    Transferred

    Owner
    Novartis AG, 4002 Basel → Bausch + Lomb Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin, Ireland 24, Ireland
    Representative
    Murgitroyd & Company, 4, rue du Commerce, 1204 Genève

    Published in Swissreg on 06.06.2024

  2. Oct 24, 2019

    Agent removed

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, Postfach 1021, 8032 Zürich (removed)

    Published in Swissreg on 24.10.2019

  3. Oct 24, 2019

    Transferred

    Owner
    SARcode Bioscience Inc., 300 Shire Way, Lexington, Massachusetts 02421, USA → Novartis AG, 4002 Basel

    Published in Swissreg on 24.10.2019

  4. Aug 24, 2017

    Registered

    Published in Swissreg on 24.08.2017

Parties

Holder

Bausch + Lomb Ireland Limited

3013 Lake Drive, Citywest Business Campus, Dublin, Ireland 24, IE

Agent

Murgitroyd & Company

4, rue du Commerce, 1204 Genève

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.